Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Acquisitions (2019)

Historic Acquisitions for X4 Pharmaceuticals (XFOR) over the last 1 years, with Q4 2019 value amounting to $52.8 million.

  • X4 Pharmaceuticals' Acquisitions changed N/A to $52.8 million in Q4 2019 from the same period last year, while for Sep 2020 it was $52.8 million, marking a year-over-year increase of 30000.0%. This contributed to the annual value of $26.4 million for FY2019, which is N/A changed from last year.
  • As of Q4 2019, X4 Pharmaceuticals' Acquisitions stood at $52.8 million.
  • Over the past 5 years, X4 Pharmaceuticals' Acquisitions peaked at $52.8 million during Q4 2019, and registered a low of -$26.4 million during Q1 2019.